Title: Global Wilson’s Disease Market: Industry Analysis & Outlook (2016-2020) - New Report by Koncept Analytics
1Global Wilsons Disease Market Industry
Analysis Outlook ------------------------------
---------- (2016-2020)
View Report Details
2View Report Details
- Executive Summary
- Wilsons disease is a rare disease and is named
after Kinnear Wilson who was the first to
describe this disorder in 1912. His description
terms the disease as a progressive lenticular
degeneration, a hereditary, fatal neurological
disease that is usually accompanied by chronic
liver ailment that leads to a condition called
cirrhosis. Wilson's disease is a hereditary
disorder that leads to unwarranted accumulation
of copper in crucial organs such as the liver,
brain etc. The patient starts to accumulate
copper from birth but diagnosis tends not to
occur only in the later ages. The primary signs
of Wilsons disease become prominent usually
between the ages of 12 and 23 years. - Wilsons disease is caused by the mutation of a
gene named ATP7B. Absent or reduced function of
ATP7B protein leads to reduced elimination of
copper into the bile. Wilsons disease is
inherited as an autosomal recessive trait, which
means that in order to develop the disease one
must inherit two procreations of the defective
gene, one from each parent. If a person receives
only one abnormal gene from either of the
parents, he/she is not likely to get affected by
the Wilsons disease. Wilsons disease may be
difficult to primarily diagnose as the symptoms
are alike to other health issues like heavy metal
poisoning, hepatitis C, and cerebral palsy. - The important factors that are anticipated to
drive the market include rising prices of
chelators in the US, rising attractiveness of
orphan drugs market, increasing global healthcare
expenditure as well as spending on medicines. The
noteworthy trends in the market include falling
number of prescriptions for Wilsons disease, and
the development of gene therapy as a potential
cure for the disease. However, the market is
confronted by crucial challenges such as
under-diagnosis of the disease, lack of safety in
treatments, poor compliance to current treatments
and unmet efficacy needs. - This report provides a wide-ranging study of
global Wilsons disease market and also its key
regional markets such as the US and Europe.
Furthermore, market dynamics such as key trends
and development and challenges are analyzed in
depth. The global Wilsons disease industry is
highly competitive consisting of several large
corporations. The competitive landscape of the
respective market, along with the company
profiles of the leading players are also
discussed in detail.
3Though it is known that Wilsons disease is a
rare condition, the prevalence of this disease is
limited also because the occurrence of this
condition is highly underdiagnosed
Global Orphan Drugs Market Revenue Actuals
(2012-2015)
- The global orphan drugs market revenue has been
growing at a CAGR of xx during the period
spanning 2012-2015. For the year 2015, the global
orphan drugs revenue was noted to be US...
billion which has increased from US.. billion in
the year 2014. - It is noted that the prevalence of Wilsons
disease is the largest in Europe with nearly
persons being affected by it in the year 2015,
followed by the US with . persons affected by
Wilsons disease. - In terms of treatment among newly diagnosed
patients, it is noted that the market remains
highly skewed towards D-penicillamine, which
recorded a share of xx of the total market in
the year 2015
Wilsons Disease Prevalence by Region (2015)
Wilsons Disease Market by Treatment New
Patients (2015)
4Europe has the highest prevalence of Wilsons
disease in the world
Europe Wilsons Disease Prevalence Forecast
(2015-2020)
- The number of persons affected with Wilsons
disease in Europe in the year 2015, was noted to
be persons. It is forecasted that the
prevalence count will reach a sum of .. persons
by the end of the year 2020. - It is noted that in the year 2015, zinc salts
constituted xx of the total market while
chelators constituted nearly xx of the total
market in the same period. - The number of Wilsons disease patients treated
with zinc in the year 2015 is noted to be .
persons. It is forecasted that the number of
patients treated with zinc will rise at a CAGR of
xx over the period 2015-2020, attaining a total
of . persons by the end of the year 2020.
Europe Wilsons Disease Market by Treatment (2015)
Europe Wilsons Disease Patients Treated with
Zinc - Forecast (2015-2020)
5Even though the number of prescriptions for
chelators has been declining over the past few
years in the US, the continuing rise in the
prices of chelators is set to make the market
revenue grow over the forthcoming years
The US Wilsons Disease Prevalence Forecast
(2015-2020)
- The prevalence of Wilsons disease is the second
largest in the US with nearly persons affected
by it in the year 2015. It is forecasted that the
prevalence of this disease will grow rather
gradually at a CAGR of xx over the forthcoming
period spanning 2015-2020. - It is forecasted that the market revenue of
copper chelators for Wilsons disease in the US
will grow at a CAGR of xx over the period
spanning 2016-2020, attaining total revenue of
US.... million by the end of 2020. - The total number of patients treated with
chelators in 2015, was recorded to be .. persons
in the US. It is forecasted that the number of
patients treated with chelators will attain a sum
of . persons by the end of 2020.
The US Chelators Market Revenue Forecast
(2016-2020)
The US Wilsons Disease Patients Treated with
Chelators Forecast (2015-2020)
6Contact Us
View Report Details
These are abridged and sanitized sample pages
from the comprehensive report on the Global
Wilson Disease Market . To know more about this
report or for any customized research
requirement, please contact the following
Koncept Analytics CS-36, Second Floor, Ansal
Plaza Vaishali, Ghaziabad, U.P. 201010 T.
91-120-4130959 C 91-9811715635
vikas_at_konceptanalytics.com
Vikas Gupta BD Manager
www.konceptanalytics.com